Allogeneic cell therapy stands out in the field of cell and gene therapy for its scalability requirements with challenges similar to those of traditional biologics. A key challenge is the ability of the allogeneic manufacturing platforms to support growth of living cells for a large patient pool. The right partner can help you accomplish this and establish a robust, efficient, and scalable process that meets commercial demand. As you navigate in the evolving cell and gene environment, trust in your partner to deliver becomes critical. Flexible capacity to grow with your project will come into play and become an underlying key success factor for the long run.
Supporting your therapy from concept to patient
By partnering with us, you partner with a growing team of scientists who have expertise in the development and manufacture (isolation, generation, banking, expansion and/or differentiation) of a broad spectrum of cell types including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), T-cells, natural killer cells (NK cells) and many others.
First-class expertise in manufacturing a broad spectrum of cell therapies
|Cell and Product Type||Capabilities|
|Induced pluripotent stem cells (iPSC)||
|T-cells and Natural killer (NK) cells||
|Mesenchymal stem cells (MSC)||
|Exosomes and other extracellular vesicles (EVs)||
|Hematopoietic stem cells (CD34+ stem cells)||
|Human pluripotent stem cells (hPSCs)||
|Immortalized and engineered cell lines||
|Tissue engineered product||
Our allogeneic services are based on a technology portfolio that enables robust and cost-efficient manufacturing for high production volumes of a single donor’s living cells.
Why choose us?
- 20+ years of cell and gene therapy GMP expertise
- >120 process development projects in cell and gene therapy
- World's first reported iPSC GMP bank
- Scale-up expertise with 2D and 3D manufacturing platforms
- >75 allogeneic cell therapy customers served globally
- Expertise and regulatory consulting throughout your journey
- Tissue acquisition dedicated team
- An integrated offer of meda/buffers, viral and non-viral modification and consumables
cell and gene therapies
allogeneic cell therapy centers of excellence
Houston, TX, USA
Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing, Viral Vector Manufacturing
Geleen, The Netherlands
Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing, Process Development, Analytical Development
Portsmouth, NH, USA
Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing